Company Earnings
Featured
More on Company Earnings
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
We maintain our fair value estimates on the share classes after earnings.
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
With an improved earnings outlook, here’s what we think of Ford’s stock.
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
We’re raising our fair value estimate of Amgen stock.
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
Recapping Morningstar analysts’ takes on earnings for these key drivers of stock market performance.
Apple Earnings: A Weak 2024, but Optimism for 2025
Raising fair value estimate of Apple stock amid higher iPhone expectations.
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
We still view Albemarle stock as materially undervalued.
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
With accelerating revenue growth and its AI push, here’s what we think of Alphabet’s stock.
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
High obesity drug demand and a scarcity of supply have driven its stock above its intrinsic value.
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
With price increases driving revenue gains, here’s what we think of Verizon stock.
Cognizant Earnings: Improved Profitability Buttresses Results as Customer Spending Remains Muted
We continue to view Cognizant as a moaty IT service vendor with a strong growth and margin profile.
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
The outlook for the refining market remains robust, with strong demand and limited capacity additions.
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
With improved free cash flow, here’s what we think of AT&T stock.
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
With strong third-quarter results, here’s what we think of Microsoft stock.
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
We think the current environment highlights the solid growth Mastercard can achieve over time.
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
We continue to view Pfizer stock as undervalued.